US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

695.95

-5.0935-0.73%

Number of Gainers:71

Number of Losers:74

Number of Flat:9

PE:- -

High:703.53

Open:700.98

Low:689.06

Close:700.98

Volume:117.01M

Turnover:4.13B

Market Cap:486.21B

Float Cap:369.41B

Loading ...

Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says

MT Newswires Live

Summit Therapeutics falls -8.5%

Mobix Labs Guides Q4 Revenue up Approximately 100% Sequentially at Midpoint

THOMSON REUTERS

Galera Therapeutics Inc trading halted, volatility trading pause

Analysts Offer Insights on Industrial Goods Companies: ACCO Brands (ACCO) and First Advantage (FA)

Dermata Therapeutics Announces Private Placement to Fund DTC Pivot

AbSci (ABSI) Receives a Hold from Morgan Stanley

SentinelOne Shares Down 3.5% Premarket After Deutsche Bank Cuts to Hold from Buy

THOMSON REUTERS

Similarweb CEO or Offer Sells $5.60 Million in Common Shares

Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged

Full Truck Alliance Co. Ltd. Expected to Post Earnings of Cny1.23 a Share - Earnings Preview

Eco Wave Power Says May Peak Output at Jaffa Port Rises to 39.1 kW During Stronger Waves

Dermata Therapeutics Prices USD 3.4 Million Private Placement at USD 1.46 Per Share

Riskified Says May Flight Fraud Risk Rises 32% as Travel Scammers Mimic Legitimate Behavior

AppLovin Price Target Cut to $440.00/Share from $500.00 by Benchmark

Press Release: Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Mobix Labs - Guides Fiscal Q4 2026 Revenue of $1.40 Mln-$1.80 Mln

THOMSON REUTERS

Mobix Labs Forecasts Fiscal Q4 Revenue of $1.4 Million-$1.8 Million

Acurx Pharmaceuticals Receives FDA Conditional Acceptance and Uspto Trademark Allowance for the Company's Brand Name for Ibezapolstat

THOMSON REUTERS

Benchmark Adjusts Price Target on AppLovin to $440 From $500, Keeps Buy Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4539/news?page=22"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":695.8834,"timestamp":1787586797720,"preClose":700.9769,"halted":0,"volume":116945869,"delay":0,"changeRate":-0.007266,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-5.093506,"latestTime":"08-24 11:53:17 EDT","open":700.9787,"high":703.53143,"low":689.0618,"amount":4127390620.978533,"amplitude":0.020642,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.245326,"peRate":150.969108,"turnoverRate":0.009035,"increases":71,"decrements":74,"flats":6,"marketCap":486208245398.875,"floatMarketCap":369409019727.5625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":703.53143,"amplitude":0.020642,"preClose":700.9769,"low":689.0618,"pbRate":"5.245326","latestPrice":695.9528,"volume":117005170,"delay":0,"open":700.9787,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":666.772,"twentyDayClose":702.6321,"sixtyDayClose":754.549,"secType":"PLATE","market":"US","turnoverRate":0.009038,"peRate":150.969108,"marketCap":486262678336.875,"floatMarketCap":369455059094.5625,"timestamp":1787586802098,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":71,"down":74,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:22,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660435025","title":"Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660435025","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660435025?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:01","pubTimestamp":1786978897,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics , Disc Medicine , and Recursion Pharmaceuticals  are making meaningful pipeline progress, with key clinical and regulatory catalysts ahead in 2026, Morgan Stanley said in a note Monday.Contineum had a solid Q2, with the company advancing PIPE-791 toward a potentially large idiopathic pulmonary fibrosis opportunity, backed by strong trial progress, better tolerability, additional chronic-pain potential, and enough cash to fund operations through mid-2029, the investment firm said.Morgan Stanley said Disc Medicine is seeing \"very strong\" demand for bitopertin, with its expanded access program launched ahead of a phase 3 trial readout expected in Q4. Management says demand is currently limited by operational bandwidth, not patient interest, according to the note.Recursion Pharmaceuticals is showing growing validation of its artificial intelligence drug-discovery platform, the firm said. The company cut its 2026 cash spending forecast to about $375 million from rough","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTNM","BK4611","IRON","LU0053671581.USD","BK4548","BK4139","RXRX","BK4007","BK4609","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660058433","title":"Summit Therapeutics falls -8.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660058433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660058433?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:05","pubTimestamp":1786975525,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) is down -8.5%, or -$1.13 to $12.22. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-falls-8-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-falls-8-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007","SMMT","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660703438","title":"Mobix Labs Guides Q4 Revenue up Approximately 100% Sequentially at Midpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2660703438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660703438?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:40","pubTimestamp":1786974000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUAWFKWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4141","MOBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660643802","title":"Galera Therapeutics Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2660643802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660643802?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:35","pubTimestamp":1786973748,"startTime":"0","endTime":"0","summary":"09:30 EDT Galera Therapeutics Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-mo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galera-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galera-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JULD","QQQP","BK4139","BK4007","LENZ","RSEE","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438994","title":"Analysts Offer Insights on Industrial Goods Companies: ACCO Brands (ACCO) and First Advantage (FA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438994?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:20","pubTimestamp":1786972808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on ACCO Brands (ACCO) and First Advantage (FA) wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-industrial-goods-companies-acco-brands-acco-and-first-advantage-fa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-industrial-goods-companies-acco-brands-acco-and-first-advantage-fa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4130","BK4535","ACCO","FA","BK4143","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660148000","title":"Dermata Therapeutics Announces Private Placement to Fund DTC Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=2660148000","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660148000?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971686,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) just unveiled an update. On August 16, 2026, Dermata Therapeutics entered into definitive securities purchase agre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-announces-private-placement-to-fund-dtc-pivot?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-announces-private-placement-to-fund-dtc-pivot?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","DRMA","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480048","title":"AbSci (ABSI) Receives a Hold from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480048?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:58","pubTimestamp":1786971496,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on AbSci, with a price target of $10.00. According to TipRanks...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/absci-absi-receives-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/absci-absi-receives-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ARKG","ABSI","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448067","title":"SentinelOne Shares Down 3.5% Premarket After Deutsche Bank Cuts to Hold from Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448067?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:47","pubTimestamp":1786970850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4560","S","BK4097","BK4585","BK4561","BK4539","LU2286300806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660803964","title":"Similarweb CEO or Offer Sells $5.60 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660803964","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660803964?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:39","pubTimestamp":1786970370,"startTime":"0","endTime":"0","summary":"Similarweb CEO Or Offer sells $5.60 million in common sharesSimilarWeb CEO Or Offer sold 709,597 ordinary shares on Aug. 13-14 at prices around $8.75 to $8.9.Sales followed option exercises for 563,49","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL5Z8v8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Similarweb CEO or Offer Sells $5.60 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMWB","BK4539","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660353480","title":"Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2660353480","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660353480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:38","pubTimestamp":1786970310,"startTime":"0","endTime":"0","summary":"Cancer immunotherapy developer CEL-SCI's Q3 net loss unchangedOverviewUS cancer immunotherapy developer's fiscal Q3 net loss was unchanged from prior yearBasic and diluted net loss per share narrowed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL1N44E0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPO","BK4007","BK4539","CVM","HCWB","ENVB","BK4196","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487070","title":"Full Truck Alliance Co. Ltd. Expected to Post Earnings of Cny1.23 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487070","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487070?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:34","pubTimestamp":1786970046,"startTime":"0","endTime":"0","summary":"Full Truck Alliance Co. Ltd. <YMM.N> expected to post earnings of CNY1.23 a share - Earnings PreviewFull Truck Alliance Co. Ltd.YMM.N,YMMis expected to  show a fall in quarterly revenue when it report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL8N44E0PG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","LU2247934214.USD","LU0261950470.USD","LU0048575426.USD","BK4232","LU0359202008.SGD","LU0456842615.SGD","LU2242644610.SGD","LU0251143458.SGD","LU0502904849.HKD","BK4022","BK4503","IE00BYTNYN87.SGD","YMM","IE00B12V2V27.USD","LU0359201885.HKD","BK4548","LU0572944931.SGD","LU0455707207.USD","LU0327786744.USD","BK4526","SG9999011746.SGD","LU0359201612.USD","BK4539","IE00BYQNZ168.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660099487","title":"Eco Wave Power Says May Peak Output at Jaffa Port Rises to 39.1 kW During Stronger Waves","url":"https://stock-news.laohu8.com/highlight/detail?id=2660099487","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660099487?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:32","pubTimestamp":1786969945,"startTime":"0","endTime":"0","summary":"Eco Wave Power says May peak output at Jaffa Port rises to 39.1 kW during stronger wavesEco Wave Power reported April–May 2026 output from its grid-connected EWP-EDF One station at Jaffa Port, Israel.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL3G1TzN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4133","BK4539","WAVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487799","title":"Dermata Therapeutics Prices USD 3.4 Million Private Placement at USD 1.46 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487799?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969849,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics prices USD 3.4 million private placement at USD 1.46 per shareDermata Therapeutics priced a private placement at-the-market under Nasdaq rules, issuing 2,293,608 common shares or ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL8q9Vc9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","DRMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660725487","title":"Riskified Says May Flight Fraud Risk Rises 32% as Travel Scammers Mimic Legitimate Behavior","url":"https://stock-news.laohu8.com/highlight/detail?id=2660725487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660725487?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969846,"startTime":"0","endTime":"0","summary":"Riskified says May flight fraud risk rises 32% as travel scammers mimic legitimate behaviorRiskified reported flight fraud risk rose through the first five months of 2026, with May up 32% year over ye","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL3wrvlH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","RSKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487745","title":"AppLovin Price Target Cut to $440.00/Share from $500.00 by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487745?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:28","pubTimestamp":1786969680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APP/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APP","BK4585","LU2063271972.USD","LU2087625088.SGD","BK4539","APPX","LU2360106780.USD","LU2290526834.HKD","LU0154236417.USD","IE00B894F039.SGD","BK4023","IE00BZ9MQY76.HKD","BK4608","LU1861215975.USD","BK4613","LU0056508442.USD","LU1861220033.SGD","XDAT","LU2250418816.HKD","BK4588","IE00B19Z9Z06.USD","LU0353189763.USD","LU2360107168.USD","IE00B19Z9P08.USD","LU0353189680.USD","CLOD","LU0097036916.USD","LU1852331112.SGD","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487499","title":"Press Release: Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487499","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487499?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:20","pubTimestamp":1786969200,"startTime":"0","endTime":"0","summary":"Differentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term GrowthHOUSTON, Aug. 17, 2026  -- Nuo Therapeutics, Inc.  , a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the second quarter ended June 30, 2026 and provided an operational and business update.Second Quarter and First Half 2026 Financial Summary-- Total revenues of approximately $1.77 million and $3.07 million for the. second quarter 2026 and first half of 2026, respectively, were each up in. -- Total 2Q product revenues increased 38% sequentially versus 1Q 2026 with. Aurix branded product revenues increasing in excess of 30% sequentially. -- Second quarter net operating loss of approximately $167,000 improved by. approximately $280,000 compared to the first quarter of 2026. -- Amended and restated loan agreement with an interim funding of $675,000. and with $325,000 remaining available under commitm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","BK4007","BK4139","AURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487862","title":"Mobix Labs - Guides Fiscal Q4 2026 Revenue of $1.40 Mln-$1.80 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487862?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968406,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","MOBX","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248279","title":"Mobix Labs Forecasts Fiscal Q4 Revenue of $1.4 Million-$1.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248279","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248279?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968143,"startTime":"0","endTime":"0","summary":"Mobix Labs forecasts fiscal Q4 revenue of $1.4 million-$1.8 millionMobix Labs guided fiscal Q4 2026 revenue of $1.4 million to $1.8 million.Midpoint implies about 100% sequential growth versus the pri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9xjBgK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBX","BK4539","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482224","title":"Acurx Pharmaceuticals Receives FDA Conditional Acceptance and Uspto Trademark Allowance for the Company's Brand Name for Ibezapolstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482224","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482224?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:01","pubTimestamp":1786968060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUA4R5JMM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","ACXP","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660818214","title":"Benchmark Adjusts Price Target on AppLovin to $440 From $500, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660818214","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660818214?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:20","pubTimestamp":1786962005,"startTime":"0","endTime":"0","summary":"AppLovin (APP) has an average rating of buy and mean price target of $550.93, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4009","LU2360107168.USD","BK4023","LU2063271972.USD","LU0056508442.USD","BK4539","LU0353189680.USD","BK4608","LU0353189763.USD","LU0154236417.USD","LU2250418816.HKD","BK4585","IE00BZ9MQY76.HKD","LU2087625088.SGD","LU2290526834.HKD","LU0097036916.USD","LU1852331112.SGD","BK4588","APP","LU1861220033.SGD","BK4613","LU1861215975.USD","LU2360106780.USD","APPX","IE00B19Z9Z06.USD","IE00B894F039.SGD","CLOD","XDAT","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":56,"pageCount":22,"totalSize":1117,"code":"91000000","status":"200"}]}}